Cogent Biosciences (COGT) Operating Income: 2017-2020
Historic Operating Income for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to -$11.5 million.
- Cogent Biosciences' Operating Income fell 611.43% to -$11.5 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$82.2 million, marking a year-over-year decrease of 155.45%. This contributed to the annual value of -$82.2 million for FY2020, which is 155.45% down from last year.
- Per Cogent Biosciences' latest filing, its Operating Income stood at -$11.5 million for Q4 2020, which was up 79.97% from -$57.2 million recorded in Q3 2020.
- Cogent Biosciences' 5-year Operating Income high stood at $2.2 million for Q4 2019, and its period low was -$57.2 million during Q3 2020.
- For the 3-year period, Cogent Biosciences' Operating Income averaged around -$12.5 million, with its median value being -$10.0 million (2018).
- As far as peak fluctuations go, Cogent Biosciences' Operating Income soared by 124.88% in 2019, and later slumped by 611.43% in 2020.
- Quarterly analysis of 4 years shows Cogent Biosciences' Operating Income stood at -$6.9 million in 2017, then tumbled by 30.87% to -$9.0 million in 2018, then soared by 124.88% to $2.2 million in 2019, then slumped by 611.43% to -$11.5 million in 2020.
- Its last three reported values are -$11.5 million in Q4 2020, -$57.2 million for Q3 2020, and -$7.4 million during Q2 2020.